the efficacy and safety of a fixed combination of semisynthetic human insulin ( novolin ) providing a 70:30 ratio of nph to regular insulin versus a varying ratio of semisynthetic human insulin , regular and nph ( control group ) , were compared in adult insulin-dependent and noninsulin-dependent diabetic patients whose glycemic control had been stable on customized split-mix regimens of animal insulin .
C0011860
noninsulin-dependent diabetic
C0021641
insulin